TCL Archive NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says. February 15, 2008
TCL Archive NIH Will Target Genomics, Translational Research, And Training, Collins Tells Congress April 30, 2010
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
